Clinical Trial Update: Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating carboplatin and topotecan in patients with relapsed or metastatic cervical cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Topotecan (topotecan)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Cervical Cancer | Phase 1, Phase 2 | Status: COMPLETED